Fig. 2From: Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease a-d. a Overall survival (p = 0.10) (b) local recurrence-free survival (p = 0.60) (c) regional recurrence-free survival (p = 0.07) and (d) metastasis recurrence-free survival (p = 0.90) of patients with N3 HNSCC treated with upfront surgery (n = 8), radiotherapy (n = 8), or chemoradiotherapy (n = 20)Back to article page